Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
CarobWay
CarobWay Overview
The food-tech start-up CarobWay brings the nutritional treasures of the ancient carob fruit to the modern table. CarobWay offers a portfolio of sustainable science-backed products from carob, including natural ingredients for foods, beverages and dietary supplements. The company has 10-year international commercial sales agreements. Innovation and technology drive CarobWay solutions – from product development to cultivation to production.
Clean-label bioactive products for well-being and functional ingredients: • Sweetener with low glycemic index: Single-ingredient syrup for products targeted to consumers with pre-diabetes • Prebiotic fibers: Standalone supplements and food fortifiers that promote gut health and support the microbiome • Food thickeners: Locust bean gum key to infant, adult and sports nutrition and dairy products
Pipeline products: • D-pinitol: Helps regulate insulin • Extracts for cosmetics • Protein
Sustainability: CarobWay strives to live in harmony with the planet and its inhabitants. Company research has selected the ideal source trees, known for climate resilience and carbon storage. Native Israeli CarobWay trees thrive under unstable precipitation, adapt to drought conditions and need minimal irrigation. Intensive cultivation prioritizes water/energy conservation and uses mechanized harvesting. Strategic company solutions bolster ecosystem diversity. Chemical-free, solar-powered processing relies solely on water and steam.
Zero waste: Preserving all of carob’s goodness, CarobWay uses 100% of the fruit to create differentiated products.
Stable supply chain for food security: CarobWay’s vertically integrated operation champions fair trade with 20+ long-term agricultural partnerships covering 300 hectares of cross-Israel cultivation.
Completed: • Full production scale-up • Prebiotics research showing significant positive microbiome effects
Financials: Earned ~€200K annually since 2022; closed ~$1M; expecting to close $5M in Q1 2024